DnB Asset Management
MBX

DnB Asset Management’s MBX Biosciences MBX Stock Holding History

DnB Asset Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Buy
+7,793
New +$272K ﹤0.01% 860

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DnB Asset Management's MBX Position: Q2 2026 in Review

DnB Asset Management opened a new position in MBX Biosciences (MBX) in Q2 2026: 7,793 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #860 among its holdings.

173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • DnB Asset Management held 7,793 shares of MBX Biosciences worth $430K as of Q2 2026.
  • MBX Biosciences was a new DnB Asset Management position in Q2 2026.
  • MBX Biosciences made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #860 holding.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.